Additional Content Download
The Cold Chain Global Forum is the largest exhibition of solutions and services for temperature controlled life science products. Don't just take our word for it - see and hear it for yourself, we guarantee you'll be impressed.
Join Gilles Jr. Gregoire, Global Transport Manager, Pharmascience as he discusses topics that include; the 3 biggest cold chain packaging trends of 2017, real time temp monitoring technologies, the growing trend towards “direct to patient” deliveries and much more.
Join Claude Jolicoeur, Director of Regulatory Affairs, McKesson Canada Corp as he discusses topics that include; changes within the supply chian industry on capturring and shareing data, real time temp monitoring technologies,cold chain challenges wihtin the Canadian market and much more.
Join Andrea L. Guisbert-Williams, Project Manager, North American Logistics Operations, Eli Lilly & Company in an exclusive interview about the effect of growth of biologic based products on temp controlled operations, next generation medicines, and her case study, Discovering Eli Lilly’s Plan to Achieve Cost Savings & Sustainability Through a Switch from Air to Ocean.
For the 15th Annual Global Forum, we re-released some of the most well received industry content from 2016's event.
Take a look at our Global Forum Content Pack or request an emailed copy that includes:
- In-depth report on "Standardization and Risk Management in the Cold Chain"
- Best Practice Guidebook for "Packaging Design & Qualification in Temperature Controlled Logistics"
- Global Mastery eBook featuring interviews with Eli Lilly, Amgen, McKesson, Novartis LatAm and many more
Email email@example.com to request an emailed copy.
What will technologies will disrupt the life sciences supply chain industry in 2018? To find out, we sat down with Paul Zikopoulos, VP of Competitive and Big Data Analytics Teams and Future Trends Expert, IBM, and the 2017 Global Forum's keynote speaker.
In meeting the growth ahead for clinical trials there must be a focus on efficiency as their supply already suffers from major issues with wastage levels. This is lack of control is problematic with the rising public scrutiny on spending by pharmaceutical companies.
Forecasting and demand planning
When sites are under supplied, sponsors may be forced to halt enrolment or even freeze patient treatments. This could have a large influence on the outcomes of a trial. Due to a range of factors, study design, patient enrolment, quantity of sites, site location, that can suddenly change the level of supplies needed for a trial to run, supply managers reduce the risk of stock outs by supplying a surplus of medicine. This in many cases spills over to become overage – when the investigational medicines have to be wasted at the end of a trial or hit their expiry dates before consumption.
Tom Bonkenburg is a partner in St. Onge Company, an international supply chain engineering and consulting firm. Since its founding in 1983, St. Onge Company has preformed over 4000 assignments for over 700 clients in over 40 countries and now has offices in the US, Europe, Middle East, and Asia.
Mr. Bonkenburg will discuss the latest available robotic technology, talk about the companies that are using this technology, and what the supply chain professional needs to know now about the possible future impact of this rapidly developing industry.
A Conversation with Tom Bonkenburg Director, European Operations, St. Onge Company where he shares why you can't afford to fall behind the pharma supply chain robotics revoloution.
While base rates stand as the bulk of shipping and freight costs, accessorial fees can cause a significant increase in the total expense. Learn about some of the most common accessorial fees, the influence they can have on your supply chain and how to reduce or avoid them.
Download this infographic and use as a resource to slash your shipping costs.
- What’s what: Definitions of the fees to expect within shipping regarding weight and density, additional fees and origin vs destination.
- Tips and tricks: On how to best minimize these fees and acquire savings.
Experts have asserted that despite recent developments, pharmaceutical supply chains are still far from reaching their full technological potential. However, Blockchain holds significant promise to advance the digital strength of medicine supply. In this whitepaper, we explore:
- What is blockchain and how can it be applied to cold chain?
- Who in life sciences is currently using blockchain and for what?
- How will the emergence of blockchain impact the industry over the next decade?
Plus! We provide an overview of potential use cases for block chain such as:
- Leveraging R&D data for collaborative research
- Dynamic pricing managed for raw materials
- Compliance and quality tracking
- Pharmacovigilance reporting
- Temperature control
- Temperature monitoring and control
Serialization is set to revolutionize how business is done in pharma. It is a complex technical project involving engineering systems at line, distribution operation levels and enterprise IT systems, at site and global levels.
Coming back to today’s reality, and despite the years given for implementation, observers will be aware that a vast portion of the manufacturing landscape is behind schedule and is now scrambling to meet international compliance deadlines.
Download this whitepaper to discover:
- Golden rules for serialization projects
- The organizational and technical challenges that creep into serialization projects
- The dangers of leaving implementation too late
- How serialization powers pharma's digital transformation